SG11201502315YA - Method and system for in vitro developmental toxicity testing - Google Patents

Method and system for in vitro developmental toxicity testing

Info

Publication number
SG11201502315YA
SG11201502315YA SG11201502315YA SG11201502315YA SG11201502315YA SG 11201502315Y A SG11201502315Y A SG 11201502315YA SG 11201502315Y A SG11201502315Y A SG 11201502315YA SG 11201502315Y A SG11201502315Y A SG 11201502315YA SG 11201502315Y A SG11201502315Y A SG 11201502315YA
Authority
SG
Singapore
Prior art keywords
toxicity testing
developmental toxicity
vitro developmental
vitro
testing
Prior art date
Application number
SG11201502315YA
Other languages
English (en)
Inventor
Hanry Yu
Yi-Chin Toh
Jiangwa Xing
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201502315YA priority Critical patent/SG11201502315YA/en
Publication of SG11201502315YA publication Critical patent/SG11201502315YA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201502315YA 2012-09-28 2013-09-30 Method and system for in vitro developmental toxicity testing SG11201502315YA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201502315YA SG11201502315YA (en) 2012-09-28 2013-09-30 Method and system for in vitro developmental toxicity testing

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2012072427 2012-09-28
PCT/SG2013/000426 WO2014051525A1 (fr) 2012-09-28 2013-09-30 Procédé et système pour le test de la toxicité développementale in vitro
SG11201502315YA SG11201502315YA (en) 2012-09-28 2013-09-30 Method and system for in vitro developmental toxicity testing

Publications (1)

Publication Number Publication Date
SG11201502315YA true SG11201502315YA (en) 2015-04-29

Family

ID=53915188

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502315YA SG11201502315YA (en) 2012-09-28 2013-09-30 Method and system for in vitro developmental toxicity testing

Country Status (5)

Country Link
US (1) US9958433B2 (fr)
EP (1) EP2900807B1 (fr)
CN (1) CN104870633B (fr)
SG (1) SG11201502315YA (fr)
WO (1) WO2014051525A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9958433B2 (en) 2012-09-28 2018-05-01 Agency For Science, Technology And Research Method and system for in vitro developmental toxicity testing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101622537A (zh) 2006-10-02 2010-01-06 塞拉帝思股份公司 基于人类胚泡来源的干细胞和祖细胞的新型毒性分析方法
CN101641436A (zh) 2007-01-30 2010-02-03 佐治亚大学研究基金会 用于产生内胚层和中胚层细胞系及多能游走细胞（mmc）的早期中胚层细胞即稳定的中内胚层细胞群
WO2008107912A2 (fr) 2007-03-06 2008-09-12 Reliance Life Sciences Pvt. Ltd. Procédés de dosage in vitro pour classifier l'embryotoxicité de composés
CA2726563A1 (fr) 2008-06-04 2009-12-10 Proteosys Ag Biomarqueurs proteiques pour l'experimentation in vitro des toxicite et embryotoxicite developpementales de substances chimiques
EP2180042A1 (fr) * 2008-10-24 2010-04-28 Commissariat A L'energie Atomique Procédés et dispositif pour contraindre les agencements multicellulaires dans une configuration spatiale stable, stationnaire et reproductible
US9958433B2 (en) 2012-09-28 2018-05-01 Agency For Science, Technology And Research Method and system for in vitro developmental toxicity testing

Also Published As

Publication number Publication date
US9958433B2 (en) 2018-05-01
CN104870633B (zh) 2018-04-06
EP2900807B1 (fr) 2017-07-05
EP2900807A1 (fr) 2015-08-05
WO2014051525A1 (fr) 2014-04-03
EP2900807A4 (fr) 2016-06-01
CN104870633A (zh) 2015-08-26
US20150276711A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
HK1212798A1 (zh) 用於奬勵通勤者的系統和方法
EP2939232A4 (fr) Système et procédé de changement de rôle dans des environnements multi-réalités
EP2864865A4 (fr) Système et procédé pour créer des diaporamas
EP2923324A4 (fr) Système et procédé pour un encaissement simplifié
EP2783203A4 (fr) Agencement de système de test et procédé de test
EP2897009A4 (fr) Procédé d'optimisation de séquence de production et système d'optimisation de séquence de production
PL2804484T3 (pl) System i sposób zasilania masą
EP2937676A4 (fr) Système de pesage ayant fonction de pesage ininterrompue et procédé de pesage
HK1215892A1 (zh) 結合時間和地方作為基礎以分發優惠的方法和系統
PT2875460T (pt) Sistema e método de anti-clonagem
IL213462A0 (en) Stand alone wimax system and method
GB201219800D0 (en) System and method
GB2519018B (en) Temperature-controlled combustion system and method
EP2909346A4 (fr) Procédé et système pour la préparation d'échantillons
EP2631629A4 (fr) Système et procédé de fabrication d'éprouvette
SG11201500746YA (en) System and method for geothentication
LT2898159T (lt) Įtaisas ir būdas elementui atremti
HK1209514A1 (en) Micro-resource-pooling system and corresponding method thereof
HK1181526A1 (zh) 種 測試的方法和系統
ZA201305036B (en) Repair system and method
EP3017414A4 (fr) Procédé et système pour placer et présenter des annonces publicitaires
GB2502196B (en) Vibration testing system and method
SG11201503818SA (en) System and method for filtration
IL217348A0 (en) Psychometric testing method and system
SG11201502315YA (en) Method and system for in vitro developmental toxicity testing